US Patent 7642277 Non-nucleoside reverse transcriptase inhibitors
Patent 7642277 was granted and assigned to Boehringer Ingelheim on January, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7642277 Non-nucleoside reverse transcriptase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
